Eden vs SkinnyRx (2026): prices, structure, verdict

On tirzepatide, SkinnyRx↗ is cheaper: $299 versus $408 a month all-in — a $109 monthly gap, $1,308 across a year of maintenance dosing, and SkinnyRx's figure is dose-flat while Eden's structure is not.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Eden is cheaper: $198 versus $199 a month all-in — a $1 monthly gap, $12 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Eden: the record, condensed

Start with the load-bearing figure: $408 a month, all-in, is what Eden charges for tirzepatide at the 10 mg basis. Pricing steps with the dose here: from $348 at entry to $408 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $720 a year, which is why every ranking on this site uses the larger number.

A required $99/month membership is part of the deal, and part of the figure above: $309 of medication plus $99 of platform equals the $408 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #16 of 17 verified programs, with the floor $193/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $41 a month. A year at this figure: $4,896 monthly-billed.

Start with the load-bearing figure: $198 a month, all-in, is what Eden charges for semaglutide at the 2.4 mg basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

A required $99/month membership is part of the deal, and part of the figure above: $99 of medication plus $99 of platform equals the $198 that leaves your account. Judge the membership by what it includes, but compare on the total.

Context for that figure: it ranks #10 of 20 in the verified semaglutide index — $65/month above the floor (Oak Longevity, $133) — and sits $151 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,376.

Operationally at Eden: shipping included; commitment membership auto-renews; cancellation membership auto-renews until cancelled; pharmacy not publicly named — ask in writing before paying; states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Eden page · visit Eden ↗

SkinnyRx: the record, condensed

SkinnyRx’s tirzepatide program bills $299 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at SkinnyRx is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $299 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #7 of 17 verified programs, with the floor $84/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $150 a month. A year at this figure: $3,588 monthly-billed.

SkinnyRx’s semaglutide program bills $199 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

There is no membership line. $199 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #11 of 20 in the verified semaglutide index — $66/month above the floor (Oak Longevity, $133) — and sits $150 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,388.

Operationally at SkinnyRx: shipping included; commitment none; cancellation no membership on compounded programs; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the SkinnyRx page · visit SkinnyRx ↗

Tirzepatide: the duel in full

Put the two tirzepatide figures side by side and hold them there: SkinnyRx at $299, Eden at $408 — a $109 monthly spread that compounds to $1,308 over a maintenance year and $2,616 over two.

Structure sharpens the gap: SkinnyRx’s figure is dose-flat (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill the same), while Eden’s is not — so SkinnyRx’s number is a ceiling and Eden’s advertised entry ($348) is a floor. Comparing a ceiling to a floor flatters the floor; this site compares maintenance to maintenance, which is the table above.

Eden’s total includes a mandatory $99/month membership; SkinnyRx has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $198 (Eden) against $199 (SkinnyRx). $1 a month sounds survivable; $12 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $1 gap is exactly what it appears to be.

Eden’s total includes a mandatory $99/month membership; SkinnyRx has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

A way to feel the $109 monthly gap: over a year it funds 4.4 extra months at SkinnyRx’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $2,616, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: Eden $408/mo month-to-month against SkinnyRx $299/mo month-to-month. The order holds: SkinnyRx leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Eden $1,224 monthly; SkinnyRx $897 monthly — best path favors SkinnyRx by $327. 6 months: Eden $2,448 monthly; SkinnyRx $1,794 monthly — best path favors SkinnyRx by $654. 12 months: Eden $4,896 monthly; SkinnyRx $3,588 monthly — best path favors SkinnyRx by $1,308. 24 months: Eden $9,792 monthly; SkinnyRx $7,176 monthly — best path favors SkinnyRx by $2,616.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

The same clock, on semaglutide

3 mo: Eden $594 vs SkinnyRx $597 — $3 to Eden. 6 mo: Eden $1,188 vs SkinnyRx $1,194 — $6 to Eden. 12 mo: Eden $2,376 vs SkinnyRx $2,388 — $12 to Eden. 24 mo: Eden $4,752 vs SkinnyRx $4,776 — $24 to Eden.

Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.

§ Structure vs structure

Everything besides the price

Coverage: Eden publishes “most states”; SkinnyRx publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.

Exit terms: Eden — membership auto-renews; membership auto-renews until cancelled. SkinnyRx — none; no membership on compounded programs.

Evidence: Eden source-verified (captured 2026-08-05); SkinnyRx source-verified (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full tirzepatide index these two sit at #16 and #7 of 17: between them lie 8 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #10 and #11 of 20: between them lie 0 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Eden and SkinnyRx

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Eden: membership auto-renews until cancelled; SkinnyRx: no membership on compounded programs) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings